These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 94899)

  • 1. BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor.
    Krolick KA; Isakson PC; Uhr JW; Vitetta ES
    Immunol Rev; 1979; 48():81-106. PubMed ID: 94899
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic regulation of lymphoid tumor cells: model systems for lymphocyte function.
    Abbas AK
    Adv Immunol; 1982; 32():301-68. PubMed ID: 6180611
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation.
    Stevenson FK; Gordon J
    J Immunol; 1983 Feb; 130(2):970-3. PubMed ID: 6600259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes.
    Hough DW; Eady RP; Hamblin TJ; Stevenson FK; Stevenson GT
    J Exp Med; 1976 Oct; 144(4):960-9. PubMed ID: 62018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of the immunoglobulin G on the surface of B lymphocytes in chronic lymphocytic leukemia.
    Stevenson FK; Hamblin TJ; Stevenson GT
    J Exp Med; 1981 Dec; 154(6):1965-9. PubMed ID: 6976409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
    Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
    J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia.
    Fu SM; Chiorazzi N; Kunkel HG
    Immunol Rev; 1979; 48():23-44. PubMed ID: 232686
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target.
    Stevenson GT; Elliott EV; Stevenson FK
    Fed Proc; 1977 Aug; 36(9):2268-71. PubMed ID: 69552
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of mouse monoclonal antibodies for the analysis of idiotypes in serum of patients with chronic lymphatic leukaemia.
    de Rie MA; van Heemstra DJ; Huijgens PC; Zeijlemaker WP; Out TA; Melief CJ; von dem Borne AE
    Br J Haematol; 1988 Jan; 68(1):11-6. PubMed ID: 3257881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against urinary light chain idiotypes as agents for detection and destruction of human neoplastic B lymphocytes.
    Tutt AL; Stevenson FK; Smith JL; Stevenson GT
    J Immunol; 1983 Dec; 131(6):3058-63. PubMed ID: 6417240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotypic vaccination as a treatment for a B cell lymphoma.
    George AJ; Folkard SG; Hamblin TJ; Stevenson FK
    J Immunol; 1988 Sep; 141(6):2168-74. PubMed ID: 3049800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes.
    Stevenson FK; Hamblin TJ; Stevenson GT; Tutt AL
    J Exp Med; 1980 Dec; 152(6):1484-96. PubMed ID: 6969771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine B cell leukemia (BCL1): organ distribution and kinetics of growth as determined by fluorescence analysis with an anti-idiotypic antibody.
    Krolick KA; Isakson PC; Uhr JW; Vitetta ES
    J Immunol; 1979 Nov; 123(5):1928-35. PubMed ID: 385772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro idiotypic suppression of chronic lymphocytic leukemia lymphocytes secreting monoclonal immunoglobulin M anti-sheep erythrocyte antibody.
    Bona CA; Fauci AS
    J Clin Invest; 1980 Mar; 65(3):761-7. PubMed ID: 6986413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiotype network theory and its implications in anti-tumor immunity.
    Bona CA
    Prog Clin Biol Res; 1989; 288():215-21. PubMed ID: 2470108
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of chronic lymphocytic leukaemia with monoclonal anti-idiotypic antibody.
    Capel PJ; Preijers FW; Allebes WA; Haanen C
    Neth J Med; 1985; 28(3):112-8. PubMed ID: 3982571
    [No Abstract]   [Full Text] [Related]  

  • 19. Aberrant interaction of B-cell lymphocytic leukemia cells with antibody coated polyacrylamide beads.
    Cohen HJ
    Exp Hematol; 1983 Feb; 11(2):162-8. PubMed ID: 6601025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A monoclonal antibody produced against the surface immunoglobulin of B-prolymphocytic leukemia].
    López Nevot MA; Ruiz-Cabello F; Huelin C; Cabrera A; Garrido F
    Sangre (Barc); 1986; 31(6):751-8. PubMed ID: 3551142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.